The Valens Company Revenue and Competitors
Estimated Revenue & Valuation
- The Valens Company's estimated annual revenue is currently $26.2M per year.
- The Valens Company's estimated revenue per employee is $270,000
- The Valens Company's total funding is $169.9M.
Employee Data
- The Valens Company has 97 Employees.
- The Valens Company grew their employee count by -19% last year.
The Valens Company's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Quality and Regulatory Affairs, QAP, RP | Reveal Email/Phone |
2 | Director, Human Resources | Reveal Email/Phone |
3 | Director, Human Resources | Reveal Email/Phone |
4 | Inventory Control Coordinator | Reveal Email/Phone |
5 | Inventory Control Coordinator | Reveal Email/Phone |
The Valens Company Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $86.4M | 291 | -1% | N/A | N/A |
#2 | $563.6M | 633 | 2% | $48.6M | N/A |
#3 | $3.1M | 23 | -34% | $19.3M | N/A |
#4 | $0.2M | 9 | -40% | $10.8M | N/A |
#5 | $67.1M | 226 | -11% | N/A | N/A |
#6 | $23M | 85 | -12% | N/A | N/A |
#7 | $23.8M | 88 | -17% | $76.8M | N/A |
#8 | $83M | 286 | 3% | $298.1M | N/A |
#9 | $10.4M | 48 | -8% | N/A | N/A |
#10 | $26.2M | 97 | -19% | $169.9M | N/A |
What Is The Valens Company?
The Valens Company (TSXV:VGW) (OTC:VGWCF) is a multi-licensed, vertically-integrated cannabis company focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development. The Valens Company is the largest third-party extraction Company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. Additionally, our subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. For more information, please visit the The Valens Company website. The Company?s investor deck can be found specifically at http://thevalenscompany.com/investors/
keywords:N/A$169.9M
Total Funding
97
Number of Employees
$26.2M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
The Valens Company News
The company's financial report was headlined by $23.2 million in revenue, which represented a 26 per cent sequential increase while coming out...
The Valens Company's high-quality products are formulated for the medical, health and wellness, and recreational consumer segments, and are...
The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company...
KELOWNA, BC, Nov. 22, 2021 /CNW/ - The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that Pommies (otherwise known as Southern Cliff Brands) has been issued a micro-processing licenc ...
KELOWNA, BC, Nov. 15, 2021 /CNW/ - (TSX: VLNS) (OTCQX: VLNCF) (the "Company," "The Valens Company" or "Valens"), a leading manufacturer of cannabis products, today announced that as the next step in its Nasdaq listing process, it will be completing a three for one consolidation (the "Consolidati ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $28.4M | 98 | 34% | N/A |
#2 | $20.7M | 101 | -2% | N/A |
#3 | $7.5M | 113 | 8% | N/A |
#4 | $7.5M | 115 | 2% | N/A |
#5 | $32.7M | 121 | 3% | N/A |